anti-C-Myc Antibody (Chicken) - FITC Conjugated

Alikkam Veetil, A., Mohlin, C., Sjöström, D. J., Iribarren, C., & Ambrosetti, E. (2025). Targeting the apical domain of the transferrin receptor: Development of a new protein scaffold for cellular delivery. Protein Science. https://doi.org/10.1002/pro.70384

Krystal M. Ma et al. HIV broadly neutralizing antibody precursors to the Apex epitope induced in nonhuman primates.Sci. Immunol.10,eadt6660(2025). DOI: 10.1126/sciimmunol.adt6660

Huong, D. (2025). Genetically engineering yeast to enable autonomous release of surface-expressed streptavidin (Master’s thesis). University of Toronto.

Robert J. Ragotte, John Tam, Sean Miletic, Roger Palou, Connor Weidle, Zhijie Li, Matthias Glögl, Greg L. Beilhartz, Huazhu Liang, Kenneth D. Carr, Andrew J. Borst, Brian Coventry, Xinru Wang, John L. Rubinstein, Mike Tyers, Roman A. Melnyk, David Baker
bioRxiv 2024.08.26.609740; doi: https://doi.org/10.1101/2024.08.26.609740

Moulana A, Dupic T, Phillips AM, et al. The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution. Elife. 2023;12:e83442. Published 2023 Feb 21. doi:10.7554/eLife.83442

Criselda Jean G. Cruz, Richard Kil, Stanley Wong, Louis C. Dacquay, Denise Mirano-Bascos, Pilarita T. Rivera, and David R. McMillen
ACS Synthetic Biology 2022 11 (9), 2938-2946
DOI: 10.1021/acssynbio.2c00160

Willis JR, Berndsen ZT, Ma KM, et al. Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors. Immunity. 2022;55(11):2149-2167.e9. doi:10.1016/j.immuni.2022.09.001

Cao Y, Jian F, Zhang Z, et al. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents. Cell Rep. 2022;41(12):111845. doi:10.1016/j.celrep.2022.111845

Zhao F, Keating C, Ozorowski G, et al. Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. iScience. 2022;25(9):104914. doi:10.1016/j.isci.2022.104914

Starr TN, Greaney AJ, Dingens AS, Bloom JD. Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016. Cell Rep Med. 2021;2(4):100255. doi:10.1016/j.xcrm.2021.100255

Greaney AJ, Loes AN, Crawford KHD, et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 2021;29(3):463-476.e6. doi:10.1016/j.chom.2021.02.003

McShan, A.C., Devlin, C.A., Morozov, G.I. et al. TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap. Nat Commun 12, 3174 (2021). https://doi.org/10.1038/s41467-021-23225-6

Greaney AJ. et al. Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition, Cell Host & Microbe,Volume 29, Issue 1,2021,Pages 44-57.e9,ISSN 1931-3128, https://doi.org/10.1016/j.chom.2020.11.007.

Starr TN, Greaney AJ, Hilton SK. et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell. 2020;182(5):1295-1310.e20. doi:10.1016/j.cell.2020.08.012

Day A et al. Unintended specificity of an engineered ligand-binding protein facilitated by unpredicted plasticity of the protein fold Protein Engineering, Design & Selection, 2018, pp. 1–13 doi: 10.1093/protein/gzy031

Dou J. et al. Sampling and energy evaluation challengesin ligand binding protein design. Protein Science 2017 VOL 26:2426—2437. DOI: 10.1002/pro.3317

Steichen et al. HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies. Immunity (2016), http://dx.doi.org/10.1016/j.immuni.2016.08.016

Kalkan T. et al. Tumor Necrosis Factor-Receptor–associated Factor-4 Is a Positive Regulator of Transforming Growth Factor-β Signaling That Affects Neural Crest Formation Mol. Biol. Cell July 15, 2009 vol. 20 no. 14 3436-3450

Wright J. et al. Dominant protein interactions that influence the pathogenesis of conformational diseases J Clin Invest. 2013;123(7):3124-3134. doi:10.1172/JCI67260.

Baxter S. et al. Flow Cytometric Assays for Interrogating LAGLIDADG Homing Endonuclease DNA-Binding and Cleavage Properties Methods Mol Biol. 2013; 978: 45–61.doi: 10.1007/978-1-62703-293-3_4

Procko E. et al. Computational design of a protein-based enzyme inhibitor J Mol Biol. 2013 Sep 23; 425(18): 10.1016/j.jmb.2013.06.035.

Sage Nelson, Jokent Gaza, Seyednima Ajayebi, Ronald Masse, Raymond Pho, Cianna Scutero, Samantha Martinusen, Lawton Long, Amor Menezes, Alberto Perez, Carl Denard. PERRC: Protease Engineering with Reactant Residence Time Control. https://doi.org/10.1101/2025.03.02.641063

Sarah W. Torres, Crystal Lan, Abbigael Harthorn, Zachary Schmitz, Paul L. Blanchard, Jon Collins, and Benjamin J. Hackel.  Molecular Determinants of Affinity and Isoform Selectivity in Protein─Small Molecule Hybrid Inhibitors of Carbonic Anhydrase.  Bioconjugate Chemistry Article ASAP DOI: 10.1021/acs.bioconjchem.5c00006

Harthorn A, Windsor HK, Schmitz Z, Cheung N, Agwaramgbo E, Hackel BJ. Engineered B7-H3 Binding in Modular Gp2 Miniproteins. Biotechnol Bioeng. 2026 Apr 29. doi: 10.1002/bit.70221. Epub ahead of print. PMID: 42057327.

Hanna, Stephanie. “Protein Design for Cyclic Peptide and Small Molecule Binding.” Washington.edu, 20 Apr. 2026, digital.lib.washington.edu/researchworks/items/61305f78-9fd6-4069-bba7-0ccd25e6d0c8.